Clindamycin phosphate is a chemically synthesized clindamycin derivative that has no antibacterial activity in vitro. After entering the body, it is rapidly hydrolyzed into clindamycin to exert antibacterial activity. It has antibacterial activity against aerobic Gram-positive cocci (such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus, and Pneumococcus), anaerobic Gram-negative rods (such as Bacteroides and Fusobacterium), anaerobic Gram-positive non-spore-forming rods (such as Propionibacterium, Eubacterium, and Actinomyces), and anaerobic and microaerophilic Gram-positive rods (such as Peptococcus, microaerophilic Streptococcus, and Peptostreptococcus).

A new type of fluoroquinolone antibacterial drug, it achieves antibacterial effect by inhibiting the activity of bacterial DNA helicase and topoisomerase IV to hinder bacterial DNA replication. It is effective against aerobic bacteria, general anaerobes, and anaerobic Gram-positive and Gram-negative bacteria. It has strong antibacterial activity against clinically isolated Staphylococcus, Enterobacter, Pseudomonas aeruginosa, various Gram-negative bacteria, Pseudomonas and Prevotella bacteria. It has antibacterial effects on a variety of drug-resistant bacteria such as imipenem, cefazolin, ceftazidime, and ampicillin-resistant bacteria. It has a killing effect on Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus, especially in the dormant period, proliferation period, and stable period. It is stronger than ceftazidime against Pseudomonas aeruginosa and Staphylococcus aureus.

This product belongs to the quinolone antibacterial drug. Its main mechanism of action is to inhibit the activity of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus, hinder DNA synthesis and cause bacterial death; it has a weak inhibitory effect on human topoisomerase II. This product has the characteristics of a broad antibacterial spectrum and strong antibacterial effect. It has good antibacterial activity against G bacteria such as Staphylococcus, Streptococcus, Enterococcus, and G- bacteria such as Escherichia coli, Proteus mirabilis, Klebsiella, Enterobacter cloacae, Citrobacter, Acinetobacter calcoaceticus, Haemophilus influenzae, Moraxella catarrhalis, Pseudomonas aeruginosa, etc. This product also has good antibacterial activity against some anaerobic bacteria such as Clostridium perfringens, Fusobacterium nucleatum, Propionibacterium acnes, Porphyromonas, some Peptostreptococci, Bacteroides fragilis and Prevotella.

This product is a polypeptide hormone extracted from the thymus of calves or pigs. It has the functions of enhancing cellular immunity and regulating immune balance. It can transform stem cells produced by bone marrow into T lymphocytes, thereby enhancing cellular immunity and having little effect on humoral immunity. It is used to treat cellular immune deficiency diseases, such as thymic dysgenesis, severe mixed immunodeficiency, ataxia telangiectasia, leprosy, severe infection, recurrent oral ulcers, etc., in patients with low cellular immunity. It can also be used for viral hepatitis, malignant tumors and anti-aging.